NASDAQ: NVAX · Biotechnology
Over the past week, Novavax (NVAX) logged 10 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 20% bullish but is sharply divided: News runs 60% bullish while X sits at just 0%. Wall Street is more constructive, with 5 of 9 analysts rating NVAX a buy.
There is little buzz around NVAX this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 56% buy share sits next to a crowd that ranges from X at 0% to News at 60%. No other tracker puts the two side by side.
9 analysts have weighed in: a Buy consensus: 5 buy calls against 3 sell, with an average 12-month price target of $14.00.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 36 points above the crowd average of 20%, the professionals are more constructive than retail. The split is inside the crowd: News reads 60% bullish while X sits at 0%, a 60-point spread that single-source trackers miss.
Weekly price context: this Alpha Vantage chart keeps its own dated range; the sentiment metrics elsewhere on this page may be newer. Over the 30-day window, Novavax (NVAX) buzz held subdued around 21.8 while the price drifted up 15.7% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 5.5M shares. Over the last 7 trading days, NVAX lost 8.7%. Buzz activity in the recent week averaged 40.1 and was variable, swinging between 21.8 and 56.4. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 11 of the 16 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for NVAX and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live NVAX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 13, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Buy (5 / 1 / 3) |
| Crowd bullish (7d) | 20% |
| Avg price target | $14.00 |
| Most bullish source | News, 60% |
| Most bearish source | X, 0% |
| Sentiment spread | 60 pts |
| Mentions (7d) | 10 |
| Market cap | $1.53B |
| P/E · Forward P/E | n/a · 2.6 |
| EPS · Beta | -$1.44 · 2.5 |
| Revenue (TTM) | $413.8M · -60% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Novavax (NVAX) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 20% bullish across 3 active sources. Those sources contribute 10 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Novavax (NVAX) is fairly quiet with 1 mentions over the last 7 days; the 30-day context spans 7 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Novavax (NVAX), averaging 20% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 60% bullish and X at 0%, a 60-point spread. On the professional side, 5 of 9 analysts rate NVAX a buy.
Of the 9 analysts covering Novavax (NVAX), 5 rate it a buy, 1 a hold and 3 a sell, for a buy consensus. The average price target is $14.00. That puts the street ahead of the crowd, which averages 20% bullish.
Novavax (NVAX)'s cross-source average is bearish at 20% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. X reads 0% bullish, News reads 60% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Novavax (NVAX) at 20% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is rising across News. The sell signal carries 93/100 conviction.
News is the dominant discussion channel with 5 mentions (50% of total volume). X contributes 4 mentions and Reddit contributes 1 mention. The cross-source average is bearish at 20% bullish, while news is the only source with rising 3-day activity. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. NVAX's sell signal at 93/100 conviction reflects a bearish cross-source average at 20% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The NVAX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key